摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-Piperidin-4-yl-5-quinolin-4-yl-1,3-oxazolidin-2-one | 681278-31-9

中文名称
——
中文别名
——
英文名称
3-Piperidin-4-yl-5-quinolin-4-yl-1,3-oxazolidin-2-one
英文别名
——
3-Piperidin-4-yl-5-quinolin-4-yl-1,3-oxazolidin-2-one化学式
CAS
681278-31-9
化学式
C17H19N3O2
mdl
——
分子量
297.357
InChiKey
IEZPMXNOKZHPKF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.8
  • 重原子数:
    22
  • 可旋转键数:
    2
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.41
  • 拓扑面积:
    54.5
  • 氢给体数:
    1
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3-Piperidin-4-yl-5-quinolin-4-yl-1,3-oxazolidin-2-one1H-吲哚-2-甲醛三乙酰氧基硼氢化钠 作用下, 以 二氯甲烷 为溶剂, 生成 3-[1-(1H-indol-2-ylmethyl)piperidin-4-yl]-5-quinolin-4-yl-1,3-oxazolidin-2-one
    参考文献:
    名称:
    Oxazolidinones as novel human CCR8 antagonists
    摘要:
    High-throughput screening of the corporate compound collection led to the discovery of a novel series of N-substituted-5-aryl-oxazolidinones as potent human CCR8 antagonists. The synthesis, structure-activity relationships, and optimization of the series that led to the identification of SB-649701 (1a), are described. (c) 2006 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2006.12.076
  • 作为产物:
    描述:
    参考文献:
    名称:
    Oxazolidinones as novel human CCR8 antagonists
    摘要:
    High-throughput screening of the corporate compound collection led to the discovery of a novel series of N-substituted-5-aryl-oxazolidinones as potent human CCR8 antagonists. The synthesis, structure-activity relationships, and optimization of the series that led to the identification of SB-649701 (1a), are described. (c) 2006 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2006.12.076
点击查看最新优质反应信息

文献信息

  • [EN] COMPOUNDS<br/>[FR] COMPOSES
    申请人:SMITHKLINE BEECHAM CORP
    公开号:WO2004032856A2
    公开(公告)日:2004-04-22
    Oxazolidin-2-one of the formula as further defined herein are useful for inhibiting the chemokine receptor nominated CCR8, resulting in treatment of diseases such as asthma and the like.
查看更多